[
  {
    "ts": null,
    "headline": "DexCom (DXCM) Stock Is Up, What You Need To Know",
    "summary": "Shares of medical device company DexCom (NASDAQ:DXCM) jumped 2.6% in the morning session after the company announced it would present new product features and positive clinical data at the European Association for the Study of Diabetes (EASD) 2025 conference.",
    "url": "https://finnhub.io/api/news?id=8afc0621f879d16fd03691981425e8efe9c68b53464f536cf4f34410b8292944",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757954751,
      "headline": "DexCom (DXCM) Stock Is Up, What You Need To Know",
      "id": 136766173,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Shares of medical device company DexCom (NASDAQ:DXCM) jumped 2.6% in the morning session after the company announced it would present new product features and positive clinical data at the European Association for the Study of Diabetes (EASD) 2025 conference.",
      "url": "https://finnhub.io/api/news?id=8afc0621f879d16fd03691981425e8efe9c68b53464f536cf4f34410b8292944"
    }
  },
  {
    "ts": null,
    "headline": "Dexcom Spotlights Upcoming Feature Launches, Improved Health Outcomes and Cost-Effectiveness With Dexcom Glucose Biosensing at EASD 2025",
    "summary": "VIENNA, September 15, 2025--DexCom, Inc. (Nasdaq: DXCM), a global leader in glucose biosensing, will present new product features and a compilation of new evidence that shows the benefits of its glucose biosensing technology for people with all types of diabetes at the upcoming 61st annual European Association for the Study of Diabetes (EASD) Conference.",
    "url": "https://finnhub.io/api/news?id=3c891f383fd7ea5421575846d4d4d4bad7f5b05784defd0a67ddca3e2eb2899b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757924100,
      "headline": "Dexcom Spotlights Upcoming Feature Launches, Improved Health Outcomes and Cost-Effectiveness With Dexcom Glucose Biosensing at EASD 2025",
      "id": 136749854,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "VIENNA, September 15, 2025--DexCom, Inc. (Nasdaq: DXCM), a global leader in glucose biosensing, will present new product features and a compilation of new evidence that shows the benefits of its glucose biosensing technology for people with all types of diabetes at the upcoming 61st annual European Association for the Study of Diabetes (EASD) Conference.",
      "url": "https://finnhub.io/api/news?id=3c891f383fd7ea5421575846d4d4d4bad7f5b05784defd0a67ddca3e2eb2899b"
    }
  }
]